Literature DB >> 30363763

Transplantation for colorectal metastases: on the edge of a revolution.

Axel Andres1, Graziano Oldani1, Thierry Berney1, Philippe Compagnon1, Pål-Dag Line2,3, Christian Toso1.   

Abstract

Liver transplantation (LT) has become the standard of care for selected primary and secondary malignancies. Considered a contra-indication to transplantation until recently, unresectable colorectal liver metastases (CRLM) have gained interest since the publication of the SECA trial by the University of Oslo. It showed a 5-year overall survival of 60%, comparable to the one of standard transplant indication. This report generated multiple questions about the place of LT for CRLM and gave raise to several trials aiming at answering them. The present review is exploring this topic, defining the current state of the field, and extrapolating the future milestones.

Entities:  

Keywords:  Liver transplantation (LT); colorectal liver metastases (CRLM)

Year:  2018        PMID： 30363763      PMCID： PMC6182035          DOI： 10.21037/tgh.2018.08.04

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


  46 in total

1.  Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved.

Authors:  Christian Toso; Hugo Pinto Marques; Axel Andres; Francisco Castro Sousa; René Adam; Antonio Kalil; Pierre-Alain Clavien; Emanuel Furtado; Eduardo Barroso; Henri Bismuth
Journal:  Liver Transpl       Date:  2017-08       Impact factor: 5.799

2.  Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment.

Authors:  G Sapisochin; M Facciuto; L Rubbia-Brandt; J Marti; N Mehta; F Y Yao; E Vibert; D Cherqui; D R Grant; R Hernandez-Alejandro; C H Dale; A Cucchetti; A Pinna; S Hwang; S G Lee; V G Agopian; R W Busuttil; S Rizvi; J K Heimbach; M Montenovo; J Reyes; M Cesaretti; O Soubrane; T Reichman; J Seal; P T W Kim; G Klintmalm; C Sposito; V Mazzaferro; P Dutkowski; P A Clavien; C Toso; P Majno; N Kneteman; C Saunders; J Bruix
Journal:  Hepatology       Date:  2016-08-24       Impact factor: 17.425

3.  "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?

Authors:  G Sapisochin; C Rodríguez de Lope; M Gastaca; J Ortiz de Urbina; M A Suarez; J Santoyo; J F Castroagudín; E Varo; R López-Andujar; F Palacios; G Sanchez Antolín; B Perez; A Guiberteau; G Blanco; M L González-Diéguez; M Rodriguez; M A Varona; M A Barrera; Y Fundora; J A Ferron; E Ramos; J Fabregat; R Ciria; S Rufian; A Otero; M A Vazquez; J A Pons; P Parrilla; G Zozaya; J I Herrero; R Charco; J Bruix
Journal:  Am J Transplant       Date:  2014-01-10       Impact factor: 8.086

4.  10th Anniversary of ALPPS-Lessons Learned and quo Vadis.

Authors:  Hauke Lang; Eduardo de Santibañes; Hans J Schlitt; Massimo Malagó; Thomas van Gulik; Marcel A Machado; Elio Jovine; Stefan Heinrich; Giuseppe Maria Ettorre; Albert Chan; Roberto Hernandez-Alejandro; Ricardo Robles Campos; Per Sandström; Michael Linecker; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2019-01       Impact factor: 12.969

5.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

6.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

7.  Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.

Authors:  Hyuk Hur; Yong Taek Ko; Byung Soh Min; Kyung Sik Kim; Jin Sub Choi; Seung Kook Sohn; Chang Hwan Cho; Heung Kyu Ko; Jong Tai Lee; Nam Kyu Kim
Journal:  Am J Surg       Date:  2008-09-11       Impact factor: 2.565

8.  Liver transplantation for unresectable perihilar cholangiocarcinoma.

Authors:  Julie K Heimbach; Gregory J Gores; Michael G Haddock; Steven R Alberts; Scott L Nyberg; Michael B Ishitani; Charles B Rosen
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

9.  FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

Authors:  Chiara Cremolini; Fotios Loupakis; Carlotta Antoniotti; Cristiana Lupi; Elisa Sensi; Sara Lonardi; Silvia Mezi; Gianluca Tomasello; Monica Ronzoni; Alberto Zaniboni; Giuseppe Tonini; Chiara Carlomagno; Giacomo Allegrini; Silvana Chiara; Mauro D'Amico; Cristina Granetto; Marina Cazzaniga; Luca Boni; Gabriella Fontanini; Alfredo Falcone
Journal:  Lancet Oncol       Date:  2015-08-31       Impact factor: 41.316

10.  Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.

Authors:  Christian Toso; Sonal Asthana; David L Bigam; A M James Shapiro; Norman M Kneteman
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425
View more
  1 in total

1.  Pushing the limits of liver surgery for colorectal liver metastases: Current state and future directions.

Authors:  Raphael Lc Araujo; Marcelo M Linhares
Journal:  World J Gastrointest Surg       Date:  2019-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.